- Summary of development progress for tomivosertib and zotatifin and a preview of anticipated 2024 milestones- - Review of recently…
SAN DIEGO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical stage biotechnology company that is…
European Study ColoFuture and U.S. Study eAArly DETECT report sensitivity and specificity for the detection of Colorectal Cancer and Advanced…
Toronto, Ontario--(Newsfile Corp. - January 9, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a…
Phase 2 trial to assess impact of peripherally-acting CB1 inhibitor on weight loss and metabolic biomarkers related to co-morbid obesity…
ROCKVILLE, MD / ACCESSWIRE / January 8, 2024 / Theralogix, a national leader in the nutritional supplement industry, proudly announces…
Expanding Access to Specialized Wound CareEMERYVILLE, CA / ACCESSWIRE / January 8, 2024 / Jovive, a provider of patient-centric outpatient…
ROCHESTER, Minn. & OREM, Utah--(BUSINESS WIRE)--Mayo Clinic Platform, which enables global healthcare transformation through new technologies and a new approach…
NEW YORK, NY / ACCESSWIRE / January 8, 2024 / Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK:DROR), an…
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With NeurofibromatosisORLANDO, FL / ACCESSWIRE / January 8,…